October 8
BioMedTech Incubator Program Delivered by Brandon BioCatalyst’s CUREator and CSIRO Opens New Funding Round
Read more
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.
Learn more about who we areA clinical stage company developing treatment for hot flashes in cancer survivors undergoing endocrine therapy
View ProjectDeveloping disease-modifying mitochondrial therapeutics for neurodegenerative disorders
View ProjectDeveloping the next generation of CAR-T cell therapies to treat solid cancers
View ProjectCombining non-opioid analgesics and biopolymers to deliver weeks of localised pain management
View ProjectUnlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections
View ProjectGlyscend is developing novel non-absorbable polymers that are orally-delivered for the treatment of Type 2 Diabetes.
View ProjectAlfred Health is a leader in health care delivery, improvement, research and education. It strives to achieve best possible health outcomes for patients and the community by integrating clinical practice with research and education.
ViewAITHM is a flagship research institute of James Cook University based in the tropics of northern Australia. Australia’s only dedicated tropical health and medicine research institute, AITHM is focussed on solving problems of importance to the tropics, leading to improvements in health systems and healthcare delivery, improved biosecurity, and enhanced health outcomes for Australians and our neighbouring tropical nations.
ViewThe Burnet Institute is an independent, not‐for‐profit Australian organization that is unique in its approach of linking medical research with public health action to address many of the major health problems affecting disadvantaged communities. This approach allows us to develop innovative health solutions ranging from the highly technological through to those that are community-based.
ViewBrandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.
Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.
Learn moreBioMedTech Incubator Program Delivered by Brandon BioCatalyst’s CUREator and CSIRO Opens New Funding Round
Read moreGeorge Medicines strengthens global commercialization strategy for GMRx2 with exclusive Biolab Farmacêutica licensing agreement in Brazil
Read moreCUREator+ delivers $15.7 m to local BioMedTech Startups Tackling the Global Dementia Challenge
Read moreNRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to Deliver Clinical Data in Parkinson’s and Proof of Concept in ALS/MND
Read more